Variables | Category | N | Disease-free survival | Overall survival | ||
---|---|---|---|---|---|---|
Median ± SD (months) | P value | Median ± SD (months) | P value | |||
NACRT group (N= 94) | ||||||
Tumour staging | Stage 1 | 18 | 88 ± 39 | 0.026 | 88 ± 39 | 0.051 |
Stage 2 | 32 | 73 ± 40 | 76 ± 39 | |||
Stage 3 | 44 | 67 ± 37 | 74 ± 36 | |||
Lymph node harvest | < 12 | 36 | 61 ± 38 | 0.801 | 63 ± 41 | 0.436 |
≥ 12 | 58 | 80 ± 40 | 86 ± 39 | |||
Upfront surgery group (N= 163) | ||||||
Tumour staging | Stage 1 | 43 | 82 ± 38 | 0.001 | 84 ± 41 | 0.003 |
Stage 2 | 29 | 61 ± 37 | 68 ± 40 | |||
Stage 3 | 91 | 54 ± 35 | 60 ± 37 | |||
Lymph node harvest | < 12 | 17 | 61 ± 38 | 0.040 | 61 ± 39 | 0.013 |
≥ 12 | 146 | 63 ± 41 | 68 ± 38 |